JP2023532736A5 - - Google Patents

Info

Publication number
JP2023532736A5
JP2023532736A5 JP2022581583A JP2022581583A JP2023532736A5 JP 2023532736 A5 JP2023532736 A5 JP 2023532736A5 JP 2022581583 A JP2022581583 A JP 2022581583A JP 2022581583 A JP2022581583 A JP 2022581583A JP 2023532736 A5 JP2023532736 A5 JP 2023532736A5
Authority
JP
Japan
Application number
JP2022581583A
Other languages
Japanese (ja)
Other versions
JP2023532736A (ja
JPWO2022005807A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/038408 external-priority patent/WO2022005807A1/en
Publication of JP2023532736A publication Critical patent/JP2023532736A/ja
Publication of JPWO2022005807A5 publication Critical patent/JPWO2022005807A5/ja
Publication of JP2023532736A5 publication Critical patent/JP2023532736A5/ja
Pending legal-status Critical Current

Links

JP2022581583A 2020-07-02 2021-06-22 血液脳関門を通過する薬物送達のための化合物 Pending JP2023532736A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063047440P 2020-07-02 2020-07-02
US63/047,440 2020-07-02
PCT/US2021/038408 WO2022005807A1 (en) 2020-07-02 2021-06-22 Compounds for drug delivery across blood-brain barrier

Publications (3)

Publication Number Publication Date
JP2023532736A JP2023532736A (ja) 2023-07-31
JPWO2022005807A5 JPWO2022005807A5 (https=) 2024-06-27
JP2023532736A5 true JP2023532736A5 (https=) 2024-06-27

Family

ID=77317394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022581583A Pending JP2023532736A (ja) 2020-07-02 2021-06-22 血液脳関門を通過する薬物送達のための化合物

Country Status (5)

Country Link
US (1) US20230257420A1 (https=)
EP (1) EP4175715A1 (https=)
JP (1) JP2023532736A (https=)
CA (1) CA3184089A1 (https=)
WO (1) WO2022005807A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359679B2 (en) * 2001-12-11 2009-01-08 Cellgate, Inc. Guanidinium transport reagents and conjugates
US20180156826A1 (en) * 2015-06-08 2018-06-07 The Board Of Regents Of The University Of Texas Sy Stem Compositions and methods for diagnosis of autism spectrum disorder
US10849875B2 (en) * 2015-07-23 2020-12-01 University Of Houston System Cancer specific lipid targeted peptidomimetics

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021015220A2 (https=)
BR102021014044A2 (https=)
BR102021014056A2 (https=)
BR102021013929A2 (https=)
JP2023532736A5 (https=)